Form 8-K · Current report
News Corp 8-K, filed Oct 13, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000220
Summary
News Corp provided the Australian Securities Exchange with daily notices of buy-backs under its 2025 Repurchase Program, which authorizes up to US$1 billion of its Nasdaq-listed Class A and Class B common stock. The company repurchased 58,482 shares for US$1,705,539.81 on 9 October 2026 and has bought approximately US$525,243,031 of shares under the program to date.
Key points
- News Corp bought back 58,482 shares on 9 October 2026 for US$1,705,539.81, at prices between US$28.91 and US$29.35.
- Under the 2025 Repurchase Program, authorized 15 July 2025 for up to an aggregate US$1 billion of Class A and Class B common stock, News Corp has purchased approximately US$525,243,031 worth of shares to date.
- Cumulative buy-backs under the program total 13,045,264 shares for US$343,050,604.56, with prices ranging from US$22.20 (9 February 2026) to US$31.58 (27 August 2026).
- Goldman Sachs & Co. LLC is the broker for the repurchases, and no ASX-listed CDIs will be repurchased.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.